(invasive) Candida infection yeast infection
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
2 Years to 17 Years
Inclusion criteria
Inclusion criteria: Included are children on oral (with of without enteral tube) or intravenous fluconazole treatment.
Exclusion criteria
Exclusion criteria: Excluded are children from whom it is impossible to get saliva ,or who have, due to their condition, such a serious mucositis of their oral cavity that saliva is mixed with blood, are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -pharmacokinetics of fluconazole in saliva and serum in children and neonates -fluconazole saliva/serum concentration ratio in children and neonates. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Efficacy of fluconazole treatment, as measured by negative (surveillance-)cultures. -Does fluconazole reach sufficient levels in the gastrointestinal tract when the administration route is intravenous | — |
Countries
Netherlands
Outcome results
None listed